RxDoctor Payments Data

Dane Wukich, MD

Foot and Ankle Surgery · Dallas, TXNPI 1184690489

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $143,951 of the $188,785 with a category attached, or 76.3%. Arthrex accounts for 76.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $40,325 and has fallen 51.8% since, to $19,424 in 2025. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$188,785in general payments, 2019–2025

Across 64 payments — averaging $2949.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$144K
  • Advanced Oxygen Therapy Inc.$20K
  • Stryker$12K
  • Orthofix Medical, Inc.$10K
  • Pylant Medical$3K
  • Zimmer Biomet$142
  • plus $577 from 9 others
$83,735in research payments, 2019–2025

Across 56 payments — averaging $1495.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Treace Medical Concepts, Inc.$84K

What the payments were for

  • Royalty or licence$143,95176%
  • Consulting fees$37,33520%
  • Travel & lodging$3,3762%
  • Food & beverage$1,7061%
  • Education$2,4171%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$188,785 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$18,178
Medicare patients
73
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$361
Gabapentin15$240
Ondansetron Hcl16$105

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →